TIA Pipeline Accelerator Voucher Program

The Centre for Drug Candidate Optimisation (CDCO) is proud to be part of Therapeutic Innovation Australia (TIA), offering specialised support for early-stage drug discovery programs.

Through the TIA Pipeline Accelerator voucher program, eligible Australian-based researchers and SMEs can access up to $50,000 in funding (matched by applicant's organisation) to fast-track their projects. This competitive scheme is designed to provide rapid access to expert services and facilities, helping promising therapies move closer to clinical application.

Key Details:

💡Who can apply? Australian-based universities, research organisations and SMEs.

💰Funding available: Up to $50,000 (plus matched co-investment) for a 1 year program

📅Round 2 (2025–2026) is now closed. Please check back in September 2026.

Contact us

Therapeutic Innovation Australia

For an interactive map of the TIA capabilities and information on the voucher application process, please visit the TIA website.

Therapeutic Innovation Australia